Mylan announced the launch of the generic version of its EpiPen emergency allergy injector that will sell for roughly half the price of the EpiPen.

The generic is identical to the brand name product except for the packaging, and will be available in pharmacies starting next week, Mylan said today.

Mylan had promised to release the generic product after coming under intense fire by lawmakers and the public earlier this year for raising the price of the EpiPen some 500 percent in recent years.

The generic will have a list price of $300 per two-pack vs. roughly $600 for the EpiPen. The company also said it is offering a savings card for eligible patients with commercial health insurance that will provide up to $25 off the out-of-pocket cost for the generic.

Advertise with us

Mylan, which is run from executive offices in Cecil, has been under investigation by U.S. and state officials for its pricing practices.

On Thursday, attorneys general in Pennsylvania and 19 other states filed a lawsuit accusing Mylan and five other generic drug companies of conspiring to fix generic drug prices.

Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.